CCNA2 and non-small cell lung carcinoma: Our previous report demonstrated that pemetrexed induced S-phase arrest and apoptosis of human NSCLC A549 cells via both ERK-CDK2/cyclin A and ataxia telangiectasia mutated (ATM)-p53 activation pathways [21], [22].